Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8059406 | 0.89 | SLC9A1 (0.47) | SLC9A1SLC9A2 | |
| SCHEMBL8743807 | 0.85 | SLC9A1 (0.55) | SLC9A1SLC9A2 | |
| SCHEMBL8379275 | 0.85 | SLC9A1 (0.55) | SLC9A1SLC9A2 | |
| Hydrochloric Acid SCHEMBL8743826 | 0.84 | SLC9A1 (0.54) | SLC9A1SLC9A2 | |
| Hydrochloric Acid SCHEMBL8374988 | 0.84 | SLC9A1 (0.54) | SLC9A1SLC9A2 | |
| SCHEMBL8743797 | 0.84 | SLC9A1 (0.54) | SLC9A1SLC9A2 | |
| SCHEMBL8743810 | 0.84 | SLC9A1 (0.54) | SLC9A1SLC9A2 | |
| SCHEMBL8363877 | 0.84 | SLC9A1 (0.56) | SLC9A1SLC9A2 | |
| SCHEMBL8070516 | 0.83 | SLC9A1 (0.44) | SLC9A1SLC9A2 | |
| Hydrochloric Acid SCHEMBL8743806 | 0.83 | SLC9A1 (0.53) | SLC9A1SLC9A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6114393-A | ADMINISTERING A BENZOYLGUANIDINE COMPOUND ANTIPROTOZOA AGENT | HOECHST MARION ROUSSEL DEUTSCHLAND GMBH (DE) | 2000-09-05 | — | — | US | claimed |
| EP-0901788-A2 | Use of inhibitors of the sodium hydrogen exchange in the manufacture of a medicament | Hoechst Marion Roussel Deutschland GmbH (DE) | 1999-03-17 | — | — | EP | claimed |
| US-6114393-A | ADMINISTERING A BENZOYLGUANIDINE COMPOUND ANTIPROTOZOA AGENT | HOECHST MARION ROUSSEL DEUTSCHLAND GMBH (DE) | 2000-09-05 | — | — | US | disclosed |
| US-6057322-A | USEFUL IN TREATMENT OF CARDIOVASCULAR DISEASES | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-05-02 | — | — | US | disclosed |
| EP-0901788-A2 | Use of inhibitors of the sodium hydrogen exchange in the manufacture of a medicament | Hoechst Marion Roussel Deutschland GmbH (DE) | 1999-03-17 | — | — | EP | disclosed |